Prognostic factors in renal cancer and prediction models
  • Ümit Gül
  • Özgür Yaycioglu
Bull Urooncol 2011; 10: 5-10
The Relationship between Bladder Cancer and Epigenetic Alterations
  • Dr. Ata Özen
  • Dr. Ali Ülgen
  • Dr. Cavit Can
Bull Urooncol 2017; 16: 17-21 DOI: 10.4274/uob.566
Is it possible to predict BCG effectivity in the treatment of superficial bladder cancer? Are there any markers?
  • Polat Türker
  • Sinan Ekici
Bull Urooncol 2012; 11: 46-51
Immunotherapy in prostate cancer
  • Murat Lekili
Bull Urooncol 2011; 10: 82-84
Liquid Biopsy: Circulating Tumor Cells and its Impact on Follow-up/Treatment of Prostate Cancer Patients
  • Ibrahim Kulaç
Bull Urooncol 2014; 13: 196-200 DOI: 10.4274/uob.159

Original Articles

The Efficiency of Docetaxel Chemotherapy on Castration Resistant Prostate Cancer: Singe Center Experience
  • Evren Süer
  • Nurullah Hamidi
  • Mehmet Ilker Gökçe
  • Sümer Baltaci
Bull Urooncol 2017; 16: 77-80 DOI: 10.4274/uob.821
The Effect of Sex and Age Differences on Pathology Results in Primary Bladder Cancer Patients
  • Hakan Türk
  • Sitki Ün
  • Batuhan Ergani
Bull Urooncol 2017; 16: 81-85 DOI: 10.4274/uob.857
Evaluation of Effect of Lymph Node Involvement on Prognosis of Clear Cell Renal Cell Cancer and Role of Tumor Size and Grade on Prediction of Lymph Node Involvement
  • Nurullah Hamidi
  • Mehmet Ilker Gökçe
  • Evren Süer
  • Sümer Baltaci
  • Yasar Bedük
Bull Urooncol 2014; 13: 192-195 DOI: 10.4274/uob.156


Histopathologic prognostic factors in testicular tumors
  • Kutsal Yörükoglu
Bull Urooncol 2011; 10: 91-94

About Journal


Useful Links